Frenolicin B

CAS : 68930-68-7

Ref. 3D-XF183224

Informations sur le produit

• Nom: Frenolicin B
• Synonymes: (3aR,5R,11bR)-3,3a,5,11b-Tetrahydro-7-hydroxy-5-propyl-2H-furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione, (+)-Frenolicin B, 2H-Furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione, 3,3a,5,11b-tetrahydro-7-hydroxy-5-propyl-, (3aR,5R,11bR)-, 2H-Furo[3,2-b]naphtho[2,3-d]pyran-2,6,11-trione, 3,3a,5,11b-tetrahydro-7-hydroxy-5-propyl-, [3aR-(3aα,5α,11bα)]-

Description

Frenolicin B is a potent inhibitor of elastin and has been shown to induce apoptosis in human cancer cells. This protein kinase inhibitor has demonstrated significant anti-tumor activity in Chinese hamster ovary cells, as well as in various other tumor cell lines. Frenolicin B analogs have been developed as potential anticancer agents that target specific kinases involved in cancer cell growth and proliferation. Its unique ability to inhibit elastin degradation makes it a promising candidate for the treatment of diseases such as emphysema and aneurysm. Additionally, Frenolicin B has been detected in urine samples from humans, indicating its potential use as a diagnostic marker for certain diseases.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 328.32 g/mol
• Formule: C₁₈H₁₆O₆
• Degré de pureté: Min. 95%